ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Clinical trials for ESTROGEN RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new approach to keep breast cancer at bay
Disease control CompletedThis large study tested whether temporarily shutting down the ovaries and adding different hormone-blocking drugs could better prevent breast cancer from returning compared to standard treatment alone. It involved over 3,000 premenopausal women who had surgery for hormone-sensiti…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New combo therapy tested to control advanced breast cancer
Disease control CompletedThis study tested a combination of two oral drugs, palbociclib and tamoxifen, as the first treatment for women with advanced hormone-positive breast cancer that had spread. The goal was to see how long the treatment could control the cancer's growth and how well patients tolerate…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Oana Danciu, MD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Study tests quick radiation blast before surgery to shrink tumors
Disease control CompletedThis small, completed study tested whether a short, highly targeted course of radiation given before surgery was a safe and practical option for older women with early-stage, hormone-sensitive breast cancer. The goal was to see if this approach could shrink the tumor and potentia…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC